Ingenico’s WalletConnect tie-up brings stablecoin payments to in-store checkout

Ingenico’s WalletConnect tie-up brings stablecoin payments to in-store checkout

New York, Jan 13, 2026, 14:41 (EST) Payments terminal provider Ingenico announced Tuesday a partnership with WalletConnect Pay, enabling shoppers to use stablecoins at checkout and bringing crypto-style payments to everyday retail. (ingenico.com) Stablecoins are digital tokens meant to maintain a stable value, typically pegged to a currency like the U.S. dollar. Until now, they’ve mostly stayed within crypto markets. Still, payments companies are pushing them as tools to speed up transfers and reduce costs, particularly for cross-border payments. The deal comes as payments and crypto players zero in on stablecoins as a payments “rail” — a back-end channel rather
13 January 2026
Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13

Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13

NEW YORK, Jan 13, 2026, 14:32 (EST) — Regular session Shares of Ligand Pharmaceuticals Incorporated dropped 10.6% to $184.80 in Tuesday afternoon trading. The decline followed an announcement from royalty partner Travere Therapeutics that U.S. regulators extended the review period for its Filspari application, pushing the decision date to April 13. Travere said the FDA classified its latest submission as a “major amendment” but didn’t request additional safety or manufacturing data. LGND shares opened at $196.96 and fluctuated between $175.89 and $206.78. (Business Wire) The timing cuts deep, given this was a straightforward, immediate trigger for Ligand’s royalty setup. Traders
Coca-Cola stock edges up after KO sets Feb. 10 earnings date; CAGNY appearance next

Coca-Cola stock edges up after KO sets Feb. 10 earnings date; CAGNY appearance next

New York, January 13, 2026, 14:29 EST — Trading in regular session. Coca-Cola Co shares edged up about 0.5% to $70.83 on Tuesday after the company announced it will report fourth-quarter and full-year 2025 results on Feb. 10, ahead of the NYSE open, with an investor call scheduled for 8:30 a.m. ET. CEO-elect Henrique Braun and CFO John Murphy are also set to speak at the Consumer Analyst Group of New York conference in Orlando on Feb. 17. (The Coca-Cola Company) The timing is crucial, marking the next two key occasions when management must engage directly with investors rather than
American Airlines stock drops 3.5% as Delta outlook and credit-card rate-cap worries hit airline shares

American Airlines stock drops 3.5% as Delta outlook and credit-card rate-cap worries hit airline shares

New York, Jan 13, 2026, 14:28 EST — Regular session Shares of American Airlines Group dropped 3.5% to $15.44 in Tuesday’s afternoon session, lagging a softer airline sector following Delta’s latest forecast and new concerns over credit-card economics. Delta slid roughly 3%, United dropped about 1.4%, and Southwest lost around 1%. This shift is significant because airline investors have been relying more on “non-ticket” revenue—mainly loyalty programs linked to co-branded credit cards that offer points and miles. President Donald Trump’s plan to impose a one-year cap of 10% on credit-card interest rates, starting Jan. 20, has cast a spotlight on
Travere Therapeutics stock slides as FDA pushes Filspari FSGS decision into April

Travere Therapeutics stock slides as FDA pushes Filspari FSGS decision into April

New York, January 13, 2026, 14:17 (EST) — Regular session Shares of Travere Therapeutics (TVTX.O) dropped 19% to $27.56 in early afternoon trading Tuesday after the U.S. Food and Drug Administration extended its review of the kidney drug Filspari for broader use. The stock had fallen as much as 34% earlier, hitting a low of $22.35. (Reuters) The delay comes during a week investors saw as crucial for the small-cap drugmaker’s regulatory path. Winning an expanded label for focal segmental glomerulosclerosis (FSGS) would unlock a fresh market, beyond the drug’s existing approval for IgA nephropathy. Traders had pegged this decision
Pony AI stock slides nearly 10% in New York trade as rate bets reset after CPI

Pony AI stock slides nearly 10% in New York trade as rate bets reset after CPI

New York, Jan 13, 2026, 14:34 EST — Regular session Pony AI Inc shares dropped sharply on Tuesday, falling roughly 9.8% to $15.66 in afternoon trading. This slide pulled the autonomous-driving company’s stock well under Monday’s close of $17.37. The decline was significant since it targeted a high-growth stock sensitive to shifts in risk appetite and interest-rate forecasts. Tuesday’s data revealed U.S. consumer prices climbed 0.3% in December, marking a 2.7% increase from a year ago; core inflation, excluding food and energy, held steady at 2.6% year-over-year. (Bureau of Labor Statistics) Traders pushed up expectations for an earlier Federal Reserve
Amphenol stock rises as Barclays, Citi and Truist lift targets after CommScope deal closes

Amphenol stock rises as Barclays, Citi and Truist lift targets after CommScope deal closes

New York, January 13, 2026, 14:25 EST — Regular session Amphenol Corp shares climbed 2.2%, hitting $148.28 in afternoon trading Tuesday, defying the broader market slump. The S&P 500 ETF SPY and the tech-focused QQQ both slipped roughly 0.4%. The connector maker has been on the rise after finalizing its $10.5 billion acquisition of CommScope and as analysts updated their ratings on the stock. The spotlight remains on data-center and communications wiring — essentially the infrastructure behind the expansion — where even minor demand changes can swiftly alter the earnings outlook. Amphenol announced on Monday that it has finalized its
Wells Fargo stock slides ahead of earnings as credit-card rate cap talk rattles banks

Wells Fargo stock slides ahead of earnings as credit-card rate cap talk rattles banks

New York, January 13, 2026, 14:36 EST — Regular session Wells Fargo & Company shares dipped 1.6% to $93.44 in Tuesday afternoon trading, sliding to an intraday low of $93.36. The stock lost $1.52 on the session, with roughly 11.4 million shares changing hands. The decline arrives just a day ahead of the bank’s quarterly earnings, making Wells Fargo one of the last major U.S. lenders to report this week. The company is set to release its fourth-quarter 2025 results around 7:00 a.m. ET on Wednesday, followed by a conference call at 10:00 a.m. ET. (Wells Fargo Newsroom) Policy risk
WeRide stock tumbles 10%: what’s dragging WRD in Tuesday’s session

WeRide stock tumbles 10%: what’s dragging WRD in Tuesday’s session

NEW YORK, Jan 13, 2026, 14:31 EST — Regular session Shares of WeRide Inc (WRD.O) dropped roughly 10% on Tuesday, wiping out early gains and lagging behind the wider market. The stock fell 10.1% to $8.81 in afternoon trading, after closing at $9.79 on Monday, with around 6.3 million shares changing hands. The pullback follows renewed rate risk concerns after the Trump administration launched a criminal probe into Federal Reserve Chair Jerome Powell, raising doubts about the duration of restrictive policy. “Everyone we know believes in Fed independence,” JPMorgan CEO Jamie Dimon said, cautioning that pressure on the central bank
Cisco stock gains on inflation day; here’s what CSCO investors watch before Feb. 11 earnings

Cisco stock gains on inflation day; here’s what CSCO investors watch before Feb. 11 earnings

New York, January 13, 2026, 14:23 EST — Regular session Cisco Systems Inc shares climbed roughly 1.3% on Tuesday, bucking a weaker U.S. stock market as investors absorbed new inflation data and adjusted their bets on large-cap tech. The stock traded between $73.27 and $75.07, closing at $74.97. U.S. consumer prices climbed 0.3% in December, pushing annual inflation to 2.7%, according to Labor Department figures. The “core” CPI, which strips out food and energy costs, increased 0.2% for the month and stood at 2.6% year-on-year. Reuters reported the Federal Reserve is likely to keep its benchmark rate steady at 3.50%-3.75%
Regencell Bioscience (RGC) stock drops 20% in Nasdaq trade as volatility flares again

Regencell Bioscience (RGC) stock drops 20% in Nasdaq trade as volatility flares again

New York, Jan 13, 2026, 14:12 EST — Regular session Shares of Regencell Bioscience Holdings Limited dropped over 20% on Tuesday, continuing a volatile streak that has kept the Nasdaq-listed microcap in the spotlight on momentum trackers. The decline is significant because the stock has proven it can swing sharply with little notice, a pattern that can catch late buyers off guard and trigger rapid sell-offs when liquidity dries up. The spotlight returns to what usually moves this stock daily: price action and positioning, rather than a steady stream of news. Investors are asking less “what changed” and more “how
Western Digital stock ticks up as WDC sets Jan. 29 earnings, putting AI storage demand in focus

Western Digital stock ticks up as WDC sets Jan. 29 earnings, putting AI storage demand in focus

New York, January 13, 2026, 14:29 EST — Regular session Shares of Western Digital Corp climbed 1.6%, closing at $215.57 on Tuesday. The data-storage company said it will release its fiscal second-quarter results on Jan. 29, after markets close at 4 p.m. ET. During the session, shares fluctuated between $208.01 and $216.80. (Western Digital) That calendar update hits a stock already seeing rapid, sizable moves. Western Digital surged 5.8% in the previous session and has experienced several volatile swings since early January, reflecting ongoing attempts to gauge the cycle’s trajectory. (Investing.com) The surge in storage stocks is fueled by AI

Stock Market Today

iFAST share price drops 3% as markets shut; earnings next week in focus

iFAST share price drops 3% as markets shut; earnings next week in focus

7 February 2026
iFAST shares fell 3.2% to S$9.64 in heavy trading Friday, closing near the day’s low as investors awaited FY2025 results due Feb. 12. The stock is about 13% below its 52-week high. iFAST recently agreed to buy a 30% stake in Financial Alliance for S$19.6 million, pending regulatory approval. Assets under administration stood at S$30.62 billion as of Sept. 30.
Sembcorp Industries share price: what to watch after Friday dip as Feb 25 results near

Sembcorp Industries share price: what to watch after Friday dip as Feb 25 results near

7 February 2026
Sembcorp shares closed at S$6.05 on Friday, down 0.33%, as Singapore’s STI dropped 0.8%. Shareholders approved the A$6.5 billion Alinta Energy takeover on Jan 30, but the deal still faces regulatory and closing conditions. Sembcorp will release FY2025 results on Feb 25 before market open. Trading volume reached about 4.3 million shares.
Hongkong Land share price drops 4% despite fresh buyback — what investors watch next

Hongkong Land share price drops 4% despite fresh buyback — what investors watch next

7 February 2026
Hongkong Land shares fell 4.2% to US$8.18 in Singapore on Friday after the company disclosed a buyback of 170,000 shares at US$8.5252 each on Feb. 5, with plans to cancel them. The drop followed a volatile week marked by a new Singapore real estate fund launch and an expanded buyback programme. Investors are watching for the group’s annual results on March 5.
Go toTop